Qube Research & Technologies (QRT)
ABVX icon

Qube Research & Technologies (QRT)’s Abivax ABVX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$41.9M Buy
423,618
+342,402
+422% +$41.3M 0.03% 607
2026
Q2 		$10.8M Buy
+81,216
New +$9.19M 0.01% 1246
2026
Q1 		– Sell
-2,037
Closed -$275K – 3485
2025
Q4 		$275K Buy
+2,037
New +$222K ﹤0.01% 2974

Other funds holding ABVX

Helikon Investments
Helikon Investments London, United Kingdom $3.52B AUM 36.83% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $2.08B AUM 157.4% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ABVX Position: Q3 2026 in Review

Qube Research & Technologies (QRT) increased its Abivax (ABVX) stake by 422% in Q3 2026, buying an estimated $41.3M and bringing the position to 423,618 shares worth $41.9M. The position accounts for 0.03% of the portfolio, ranked #607.

Qube Research & Technologies (QRT) first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. 211 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Qube Research & Technologies (QRT) held 423,618 shares of Abivax worth $41.9M as of Q3 2026.
  • Qube Research & Technologies (QRT) bought 342,402 Abivax shares in Q3 2026, an estimated $41.3M.
  • Abivax made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #607 holding.
  • Qube Research & Technologies (QRT) first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • 211 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.